BR112012031451A2 - cloreto de glicopirrônio treo cristalino, processo para preparar cloreto de glicopirrônio treo cristalino, composição farmacêutica e uso de cloreto de glicopirrônio treo cristalino - Google Patents
cloreto de glicopirrônio treo cristalino, processo para preparar cloreto de glicopirrônio treo cristalino, composição farmacêutica e uso de cloreto de glicopirrônio treo cristalinoInfo
- Publication number
- BR112012031451A2 BR112012031451A2 BR112012031451A BR112012031451A BR112012031451A2 BR 112012031451 A2 BR112012031451 A2 BR 112012031451A2 BR 112012031451 A BR112012031451 A BR 112012031451A BR 112012031451 A BR112012031451 A BR 112012031451A BR 112012031451 A2 BR112012031451 A2 BR 112012031451A2
- Authority
- BR
- Brazil
- Prior art keywords
- treo
- crystalline
- glycopyrronium chloride
- glycopyrronium
- chloride
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 title 3
- ANGKOCUUWGHLCE-HKUYNNGSSA-N [(3s)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate Chemical compound C1[N+](C)(C)CC[C@@H]1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-HKUYNNGSSA-N 0.000 title 3
- 229960002462 glycopyrronium bromide Drugs 0.000 title 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10165786 | 2010-06-14 | ||
PCT/EP2011/002893 WO2011157387A1 (en) | 2010-06-14 | 2011-06-13 | Crystal form of glycopyrronium chloride |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012031451A2 true BR112012031451A2 (pt) | 2016-12-06 |
Family
ID=42751657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012031451A BR112012031451A2 (pt) | 2010-06-14 | 2011-06-13 | cloreto de glicopirrônio treo cristalino, processo para preparar cloreto de glicopirrônio treo cristalino, composição farmacêutica e uso de cloreto de glicopirrônio treo cristalino |
Country Status (10)
Country | Link |
---|---|
US (1) | US9174937B2 (pt) |
EP (1) | EP2580195B1 (pt) |
KR (1) | KR101736529B1 (pt) |
CN (1) | CN102939280B (pt) |
AR (1) | AR081889A1 (pt) |
BR (1) | BR112012031451A2 (pt) |
CA (1) | CA2802584C (pt) |
ES (1) | ES2528957T3 (pt) |
RU (1) | RU2569852C2 (pt) |
WO (1) | WO2011157387A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102232806B1 (ko) * | 2013-02-28 | 2021-03-29 | 더미라, 인코포레이티드 | 글리코피롤레이트 염 |
US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
MX370104B (es) | 2013-10-22 | 2019-12-02 | Chiesi Farm Spa | Proceso para la preparacion de un inhibidor de fosfodiesterasa (pde4). |
US9926270B2 (en) | 2014-08-20 | 2018-03-27 | Dermira, Inc. | Process for production of glycopyrronium tosylate |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
WO1998021183A1 (de) * | 1996-11-11 | 1998-05-22 | Noe Christian R | Enantiomerenreine, basische aryl-cycloalkyl-hydroxycarbonsäureester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
AT412088B (de) * | 2002-12-18 | 2004-09-27 | Pharmacon Forschung & Beratung Gmbh | Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere |
EP1720577A2 (en) * | 2004-02-27 | 2006-11-15 | Altana Pharma AG | Ciclesonide and glycopyrronium combination |
EP1616567A1 (en) * | 2004-07-16 | 2006-01-18 | Boehringer Ingelheim Pharma GmbH & Co.KG | Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
GB0504463D0 (en) * | 2005-03-03 | 2005-04-13 | Arakis Ltd | Method of crystallisation and purification |
US7915303B2 (en) | 2005-03-24 | 2011-03-29 | Sosei R&D Ltd. | Glycopyrronium salts and their therapeutic use |
GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
EP1894568A1 (en) * | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
CA2758100C (en) * | 2009-04-09 | 2017-08-29 | Novartis Ag | Process for preparing pyrrolidinium salts |
-
2011
- 2011-06-13 BR BR112012031451A patent/BR112012031451A2/pt not_active Application Discontinuation
- 2011-06-13 AR ARP110102059A patent/AR081889A1/es unknown
- 2011-06-13 EP EP11735781.4A patent/EP2580195B1/en active Active
- 2011-06-13 RU RU2012154006/04A patent/RU2569852C2/ru active
- 2011-06-13 WO PCT/EP2011/002893 patent/WO2011157387A1/en active Application Filing
- 2011-06-13 ES ES11735781.4T patent/ES2528957T3/es active Active
- 2011-06-13 CN CN201180029241.3A patent/CN102939280B/zh active Active
- 2011-06-13 KR KR1020127032332A patent/KR101736529B1/ko active Active
- 2011-06-13 CA CA2802584A patent/CA2802584C/en active Active
- 2011-06-14 US US13/159,922 patent/US9174937B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2580195B1 (en) | 2014-12-03 |
US9174937B2 (en) | 2015-11-03 |
CA2802584A1 (en) | 2011-12-22 |
ES2528957T3 (es) | 2015-02-13 |
CN102939280A (zh) | 2013-02-20 |
RU2012154006A (ru) | 2014-07-20 |
KR20130119844A (ko) | 2013-11-01 |
CN102939280B (zh) | 2014-11-19 |
US20110305645A1 (en) | 2011-12-15 |
WO2011157387A1 (en) | 2011-12-22 |
CA2802584C (en) | 2018-08-21 |
EP2580195A1 (en) | 2013-04-17 |
RU2569852C2 (ru) | 2015-11-27 |
KR101736529B1 (ko) | 2017-05-17 |
HK1177200A1 (en) | 2013-08-16 |
AR081889A1 (es) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1006794A2 (pt) | Processo para preparar inibidores jak e compostos intermediários relacionados | |
BR112012026843A2 (pt) | composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv | |
BR112014010460A2 (pt) | composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica | |
BR112012018829A2 (pt) | processo para preparar carboximetil celulose, carboximetil celulose e uso de carboximetil celulose | |
BR112012029929A2 (pt) | processo para preparar um produto de carga mineral tratada, produto de carga mineral tratada, uso de um produto de carga mineral tratada, e, material de película | |
BR112013014044A2 (pt) | composição, produto alimentício e processo para prepará-lo | |
BR112014001418A2 (pt) | compostos, processo para a preparação dos compostos, e, uso dos compostos | |
BR112013028959A2 (pt) | composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
BRPI0921399A2 (pt) | composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante | |
BR112012029906A2 (pt) | produto de carga mineral tratada, processo para preparar um produto de carga mineral tratada, uso de um produto de carga mineral tratada, e, material de película | |
BR112013030832A2 (pt) | processo para tratar as fibras queratínicas e uso de uma composição | |
BRPI0822946A2 (pt) | Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida | |
BR112013016365A2 (pt) | composição de lipossoma e processo para produção do mesmo | |
BR112014009684A2 (pt) | processo para preparar polímeros, polímero e uso de polímeros | |
BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
BR112012021476A2 (pt) | composto, processo para preparação do composto, composição farmacêutica compreendendo uma quantidade terapeuticamente eficaz do composto e emprego de tal composto | |
BR112014026564A2 (pt) | formulação, uso de uma formulação, e, processo para a preparação de uma formulação | |
BR112014026565A2 (pt) | formulação, uso de uma formulação, e, processo para produzir uma formulação | |
BR112013015085A2 (pt) | composição farmacêutica, método para preparar uma composição, e, uso de composição | |
BRPI1008277A2 (pt) | composição de cloreto de sódio, processo para a preparação de uma composição de cloreto de sódio e uso de uma composição de cloreto de sódio não aglomerante | |
BR112012029225A2 (pt) | processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral | |
BR112012002087A2 (pt) | Grânulos, processo para a preparação dos grânulos e uso dos grânulos | |
BR112014012561A2 (pt) | mistura de aminas, processo para preparar uma mistura de aminas, composição de combustível, e, uso de uma mistura de aminas | |
BR112012031451A2 (pt) | cloreto de glicopirrônio treo cristalino, processo para preparar cloreto de glicopirrônio treo cristalino, composição farmacêutica e uso de cloreto de glicopirrônio treo cristalino | |
BR112013005986A2 (pt) | processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |